CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
Holding CTMX?
Track your performance easily

CytomX Therapeutics (CTMX) Ownership - Who Owns CytomX Therapeutics?

570 Followers

CytomX Therapeutics (CTMX) Ownership Overview

1.69%7.56%4.10%5.20%81.44%
4.10% Other Institutional Investors
5.20% ETFs
81.44% Public Companies and
Individual Investors
The ownership structure of CytomX Therapeutics (CTMX) stock is a mix of institutional, retail, and individual investors. Approximately 16.87% of the company’s stock is owned by Institutional Investors, 1.69% is owned by Insiders, and 81.44% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 21, 2024
Sean A. Mccarthy
Ceo,director
xxxxxxxxxxxxx
$42064
Mar 21, 2024
xxxxxxxxxxxxx
$13649
Mar 21, 2024
xxxxxxxxxxxxx
$10957
Mar 21, 2024
xxxxxxxxxxxxx
$6180

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,436,953Institution4.39%3,574,431
3,166,953Institution4.05%3,293,631
820,461Institution1.05%853,279
751,009Insider0.96%781,049
668,155Institution0.85%694,881
555,119Institution0.71%577,324
369,124Institution0.47%383,889
246,001Institution0.31%255,841
176,484Institution0.23%183,543
175,648Insider0.22%182,674

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,166,953Institution4.05%3,293,631
820,461Institution1.05%853,279
668,155Institution0.85%694,881
555,119Institution0.71%577,324
369,124Institution0.47%383,889
106,678Institution0.14%110,945
46,356Institution0.06%48,210
46,219Institution0.06%48,068
44,926Institution0.06%46,723
41,458Institution0.05%43,116

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,455,462Institution3.14%2,897,445
981,491Institution1.25%1,158,159
246,001Institution0.31%255,841
172,636Institution0.22%188,173
176,484Institution0.23%183,543
37,464Institution0.05%38,963
5Institution<0.01%9

FAQ

Who Owns CytomX Therapeutics Inc (CTMX)?
According to the latest TipRanks data, approximately 4.10% of the company's stock is held by institutional investors, 1.69% is held by insiders, and 81.44% is held by retail investors.
    What percentage of CytomX Therapeutics Inc (CTMX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.10% of CytomX Therapeutics Inc (CTMX) stock is held by institutional investors.
      What percentage of CytomX Therapeutics Inc (CTMX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 81.44% of CytomX Therapeutics Inc (CTMX) stock is held by retail investors.
        Who owns the most shares of CytomX Therapeutics Inc (CTMX)?
        Vanguard owns the most shares of CytomX Therapeutics Inc (CTMX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis